Previous studies have shown that GLO1 levels and activity can be altered in disease states, including diabetes, cardiomyopathy, and endothelial dysfunction (Jack et al., 2012; Skapare et al., 2013; Hanssen et al., 2014; Yumnam et al., 2020). The gene discussed is GLO1; the disease is cardiomyopathy.